US Stock MarketDetailed Quotes

DNLI Denali Therapeutics

Watchlist
  • 22.970
  • -0.500-2.13%
Close Dec 13 16:00 ET
  • 23.890
  • +0.920+4.01%
Pre 08:20 ET
3.31BMarket Cap-8.32P/E (TTM)

Denali Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
204.74%330.53M
0
-64.40%1.27M
460.45%294.12M
-16.61%35.14M
122.90%108.46M
-17.83%10.28M
Operating revenue
--0
--0
--0
214.60%330.53M
--0
588.59%1.27M
460.45%294.12M
-16.61%35.14M
115.93%105.07M
-18.01%10.26M
Cost of revenue
Gross profit
Operating expense
7.06%123.19M
-5.70%116.59M
-15.20%132.25M
17.37%527.23M
14.65%132.57M
3.62%115.06M
8.56%123.64M
43.55%155.96M
30.43%449.21M
29.00%115.63M
Selling and administrative expenses
-1.48%24.95M
-3.55%25.19M
-7.02%25.24M
14.23%103.35M
5.33%24.77M
8.88%25.33M
23.45%26.12M
20.40%27.14M
14.44%90.48M
8.07%23.52M
-General and administrative expense
-1.48%24.95M
-3.55%25.19M
-7.02%25.24M
14.23%103.35M
5.33%24.77M
8.88%25.33M
23.45%26.12M
20.40%27.14M
14.44%90.48M
8.07%23.52M
Research and development costs
9.47%98.24M
-6.28%91.4M
-16.92%107.02M
18.16%423.88M
17.04%107.8M
2.22%89.74M
5.16%97.52M
49.62%128.82M
35.19%358.73M
35.70%92.11M
Operating profit
-8.25%-123.19M
-168.39%-116.59M
-9.47%-132.25M
42.27%-196.7M
-25.85%-132.57M
-5.87%-113.8M
377.59%170.48M
-81.68%-120.82M
-15.21%-340.74M
-36.60%-105.34M
Net non-operating interest income expense
10.75%16M
36.18%17.57M
44.22%15.91M
248.62%51.51M
97.13%13.13M
244.92%14.44M
386.98%12.9M
763.38%11.03M
221.52%14.77M
418.29%6.66M
Non-operating interest income
10.75%16M
36.18%17.57M
44.22%15.91M
248.62%51.51M
--13.13M
--14.44M
386.98%12.9M
763.38%11.03M
221.52%14.77M
----
Other net income (expense)
14.54M
Special income (charges)
--0
--0
--14.54M
----
----
--0
--0
--0
----
----
-Gain on sale of business
--0
--0
--14.54M
----
----
--0
--0
--0
----
----
Income before tax
-7.89%-107.19M
-154.00%-99.03M
7.27%-101.8M
55.46%-145.19M
-21.04%-119.44M
3.82%-99.35M
412.05%183.38M
-68.32%-109.78M
-11.96%-325.97M
-30.13%-98.68M
Income tax
42.86%30K
103.65%21K
98.96%-6K
Net income
-7.89%-107.19M
-154.00%-99.03M
7.27%-101.8M
55.45%-145.22M
-21.07%-119.47M
3.82%-99.35M
411.91%183.38M
-68.32%-109.78M
-12.19%-325.99M
-31.11%-98.68M
Net income continuous Operations
-7.89%-107.19M
-154.00%-99.03M
7.27%-101.8M
55.45%-145.22M
-21.07%-119.47M
3.82%-99.35M
411.91%183.38M
-68.32%-109.78M
-12.19%-325.99M
-31.11%-98.68M
Minority interest income
Net income attributable to the parent company
-7.89%-107.19M
-154.00%-99.03M
7.27%-101.8M
55.45%-145.22M
-21.07%-119.47M
3.82%-99.35M
411.91%183.38M
-68.32%-109.78M
-12.19%-325.99M
-31.11%-98.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-7.89%-107.19M
-154.00%-99.03M
7.27%-101.8M
55.45%-145.22M
-21.07%-119.47M
3.82%-99.35M
411.91%183.38M
-68.32%-109.78M
-12.19%-325.99M
-31.11%-98.68M
Basic earnings per share
12.50%-0.63
-144.03%-0.59
15.00%-0.68
59.23%-1.06
-14.67%-0.86
14.29%-0.72
379.17%1.34
-50.94%-0.8
-8.79%-2.6
-20.97%-0.75
Diluted earnings per share
12.50%-0.63
-145.38%-0.59
15.00%-0.68
59.23%-1.06
-14.67%-0.86
14.29%-0.72
370.83%1.3
-50.94%-0.8
-8.79%-2.6
-20.97%-0.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 000204.74%330.53M0-64.40%1.27M460.45%294.12M-16.61%35.14M122.90%108.46M-17.83%10.28M
Operating revenue --0--0--0214.60%330.53M--0588.59%1.27M460.45%294.12M-16.61%35.14M115.93%105.07M-18.01%10.26M
Cost of revenue
Gross profit
Operating expense 7.06%123.19M-5.70%116.59M-15.20%132.25M17.37%527.23M14.65%132.57M3.62%115.06M8.56%123.64M43.55%155.96M30.43%449.21M29.00%115.63M
Selling and administrative expenses -1.48%24.95M-3.55%25.19M-7.02%25.24M14.23%103.35M5.33%24.77M8.88%25.33M23.45%26.12M20.40%27.14M14.44%90.48M8.07%23.52M
-General and administrative expense -1.48%24.95M-3.55%25.19M-7.02%25.24M14.23%103.35M5.33%24.77M8.88%25.33M23.45%26.12M20.40%27.14M14.44%90.48M8.07%23.52M
Research and development costs 9.47%98.24M-6.28%91.4M-16.92%107.02M18.16%423.88M17.04%107.8M2.22%89.74M5.16%97.52M49.62%128.82M35.19%358.73M35.70%92.11M
Operating profit -8.25%-123.19M-168.39%-116.59M-9.47%-132.25M42.27%-196.7M-25.85%-132.57M-5.87%-113.8M377.59%170.48M-81.68%-120.82M-15.21%-340.74M-36.60%-105.34M
Net non-operating interest income expense 10.75%16M36.18%17.57M44.22%15.91M248.62%51.51M97.13%13.13M244.92%14.44M386.98%12.9M763.38%11.03M221.52%14.77M418.29%6.66M
Non-operating interest income 10.75%16M36.18%17.57M44.22%15.91M248.62%51.51M--13.13M--14.44M386.98%12.9M763.38%11.03M221.52%14.77M----
Other net income (expense) 14.54M
Special income (charges) --0--0--14.54M----------0--0--0--------
-Gain on sale of business --0--0--14.54M----------0--0--0--------
Income before tax -7.89%-107.19M-154.00%-99.03M7.27%-101.8M55.46%-145.19M-21.04%-119.44M3.82%-99.35M412.05%183.38M-68.32%-109.78M-11.96%-325.97M-30.13%-98.68M
Income tax 42.86%30K103.65%21K98.96%-6K
Net income -7.89%-107.19M-154.00%-99.03M7.27%-101.8M55.45%-145.22M-21.07%-119.47M3.82%-99.35M411.91%183.38M-68.32%-109.78M-12.19%-325.99M-31.11%-98.68M
Net income continuous Operations -7.89%-107.19M-154.00%-99.03M7.27%-101.8M55.45%-145.22M-21.07%-119.47M3.82%-99.35M411.91%183.38M-68.32%-109.78M-12.19%-325.99M-31.11%-98.68M
Minority interest income
Net income attributable to the parent company -7.89%-107.19M-154.00%-99.03M7.27%-101.8M55.45%-145.22M-21.07%-119.47M3.82%-99.35M411.91%183.38M-68.32%-109.78M-12.19%-325.99M-31.11%-98.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -7.89%-107.19M-154.00%-99.03M7.27%-101.8M55.45%-145.22M-21.07%-119.47M3.82%-99.35M411.91%183.38M-68.32%-109.78M-12.19%-325.99M-31.11%-98.68M
Basic earnings per share 12.50%-0.63-144.03%-0.5915.00%-0.6859.23%-1.06-14.67%-0.8614.29%-0.72379.17%1.34-50.94%-0.8-8.79%-2.6-20.97%-0.75
Diluted earnings per share 12.50%-0.63-145.38%-0.5915.00%-0.6859.23%-1.06-14.67%-0.8614.29%-0.72370.83%1.3-50.94%-0.8-8.79%-2.6-20.97%-0.75
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data